se of Probiotics in prevention of Chemotherapy induced diarrhea in patients with gastrointestinal Cancer
Not Applicable
- Conditions
- DiarrheaAntineoplastic AgentsC04.588.274.476
- Registration Number
- RBR-33wrhzd
- Lead Sponsor
- niversidade Federal de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Age between 18 and 85 years old; Diagnosis of primary gastrointestinal tract tumor (esophagus, stomach, pancreas, colon and rectum); Planning to start chemotherapy treatment with chemotherapy protocols containning irinotecan and/or fluoropyrimidines; Performance scale according to the Eastern Cooperative Oncology Group (ECOG) between 0-2
Exclusion Criteria
Severe systemic diseases including heart disease, coagulopathies, renal and hepatic dysfunction; History of severe diarrhea during previous treatment; Use of probiotics, prebiotics up to 2 months before recruitment; Pregnant and lactating women; Incapable patient; Not signed the Informed Consent Form
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method